ArticleApplied microbiology and biotechnology2026
Comparative genomic analysis of RNA-binding proteins across some drug resistant and sensitive Staphylococcus aureus.
Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The adaptability and persistence of Staphylococcus aureus in diverse host environments may be influenced by its genetic repertoire, including RNA-binding proteins (RBPs). These proteins play critical roles in regulating post-transcriptional processes; however, their significance in bacteria, particularly in pathogenic strains, remains poorly understood. This gap necessitates a comprehensive exploration of RBPs in bacterial pathogens such as S. aureus better to understand their potential contributions to virulence and adaptability. In this study, a bioinformatics-based analysis of the genomes and proteomes of 51 pathogenic S. aureus strains was conducted, focusing on their RNA-binding proteome (RBPome). The pathogenicity of all analyzed strains was confirmed, and both known and putative virulence genes were identified. In addition, strains were categorized as drug-resistant or drug-sensitive based on genomic data, providing insights into their genetic variation. Phylogenetic analysis based on single-nucleotide polymorphism (SNP) data revealed distinct groupings of major clonal complexes, highlighting evolutionary relationships among the strains. Eight conserved RNA-binding proteins were identified, and their RNA-binding domains and molecular dynamics were predicted. Notable differences in molecular phylogeny, RNA-binding domains, and dynamics were observed in cold shock proteins A and B and S1 RNA-binding domain proteins between resistant and sensitive strains. These findings suggest that RNA-binding proteins may play important roles in the pathogenicity and adaptability of S. aureus and could be potential molecular targets for future therapeutic strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.